0.1850GBp+2.78%Mkt Cap: 7.94M GBpP/E: —Last update: 2026-05-13
Oxford BioDynamics Plc, together with its subsidiaries, operates as a biotechnology company that y developing, and commercializing precision medicine tests for life-changing diseases in the United States and the United K…
Industry Peers
Diagnostics & Researchloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)—
P/E (Forward)-0.46
PEG—
P/B1.85
P/S7.25
EV/EBITDA-1.14
EV/Revenue10.65
EPS (TTM)-0.01
EPS (Forward)-0.00
Cash Flow & Leverage
FCF Yield-54.46%
FCF Margin-394.79%
Operating CF-7.57M GBp
CapEx (TTM)244.00K GBp
Net Debt/EBITDA-0.36
Net Debt3.72M GBp
Technical
SMA 500.2110 (-12.3%)
SMA 2000.3125 (-40.8%)
Beta-0.19
S&P 52W Chg24.23%
Avg Vol (30d)10.55M
Avg Vol (10d)7.43M
Technical Indicators
RSI (14)35.9
MACD-0.0090
MACD Signal-0.0054
MACD Hist.-0.0035
BB Upper0.2540 GBp
BB Middle0.2109 GBp
BB Lower0.1677 GBp
BB Width40.88%
ATR (14)0.0246 GBp
Vol Ratio (20d)0.29x
52W Range
0.17002% of range0.7800
52W High0.7800 GBp
52W Low0.1700 GBp
Profitability
Gross Margin47.67%
EBITDA Margin0.00%
Profit Margin-1018.54%
Oper. Margin-958.86%
ROE-999.37%
ROA-137.93%
Revenue Growth64.40%
Earnings Growth—
Balance Sheet
Debt/Equity4.58
Current Ratio0.88
Quick Ratio0.76
Book Value/Sh0.0010 GBp
Cash/Share0.0000 GBp
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 GBp
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Ownership
Shares Out.4.29B
Float3.07B
Insiders9.79%
Institutions41.17%
Analyst Consensus
Rating—
Target (Mean)1.000 GBp
Target Range1.000 GBp – 1.000 GBp
# Analysts1
Company
Market Cap7.94M GBp
Enterprise Value11.66M GBp
Revenue (TTM)1.09M GBp
Gross Profit522.00K GBp
Net Income (TTM)-11.15M GBp
Revenue/Share0.0010 GBp
Fiscal Year EndSep 2025
MR QuarterSep 2025
Employees41
Last Price0.1850 GBp
CountryGB
SectorHealthcare
IndustryDiagnostics & Research
ISIN—